Navigation Links
Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection

or saline (control) by intravenous injection. In the study, 50% of the Valortim-treated animals survived compared to none of the saline-treated animals.

"While post-exposure models of inhalation anthrax infection are relatively straight-forward, demonstrating efficacy in a therapeutic model for inhalation anthrax infection has proven somewhat challenging," remarked Valerie Riddle, M.D., Vice President and Medical Director for PharmAthene. "In most animal species in which anthrax has been studied, the disease course and time to death is markedly shorter than that seen in humans, making it challenging to evaluate the potential therapeutic efficacy of promising products. The model being developed by USAMRIID uses a rapidly detectable surrogate marker for the development of symptomatic disease to provide a consistent window in which to determine the therapeutic efficacy of Valortim in animals confirmed to have active disease. We believe this will be an important consideration for the licensure of novel anthrax therapeutics under the Food and Drug Administration's proposed Animal Rule."

Dr. Riddle continued, "This is a very encouraging survival result when one considers that these animals had bacteria multiplying in their blood and were poised to manifest severe symptoms and death at the time they were treated with Valortim. We plan to continue to collaborate with USAMRIID to further refine the model and determine the optimal therapeutic dose for Valortim."

"Previous studies in the rabbit animal model had suggested the capacity of Valortim to successfully treat symptomatic animals," noted Israel Lowy, M.D., Ph.D., Senior Director of Infectious Disease for Medarex. "The current studies in a non-human primate model, that may be more relevant to human disease, provide additional confirmation for those results. The methodological advances of the group at USAMRIID may help to better define the therapeutic potency of Valortim and other agents in this chall
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
2. Cethromycin Shown Effective Against Anthrax in Study
3. Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection
4. Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
5. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
6. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
7. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
8. Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in Cancer Animal Models
9. Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
10. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
11. La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent Lupus Phase 3 Trial
Post Your Comments:
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
(Date:11/30/2008)...- Abnormalities in auditory and language processin...m disorder by using magnetoencephalography (MEG), ... meeting of the Radiological Society of North Amer...he tiny magnetic fields associated with electrical...e chair of research in the Department of Radiology...
(Date:11/26/2008)... and intelligent clinical applications take workfl... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstC...ealthcare ) highlights the ACUSON S2000(TM) Autom... first multi-use, automated volume breast ultrasou...ual Meeting of the Radiological Society of North A...
(Date:11/25/2008)...ewswire/ -- Proteolix, Inc., a,leader in the disc...arget,protein degradation pathways in cancer and ...om two ongoing Phase 2 clinical trials of carfilzo...upcoming 50th Annual Meeting of the,American Soci... in a new class,of specific proteasome inhibitors...
Breaking Medicine Technology:The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3New HIV Prevention Anti Stigma Campaign Featuring HIV Positive 26 Negative Persons TOGETHER Launches Across the Nation 25536 1New HIV Prevention Anti Stigma Campaign Featuring HIV Positive 26 Negative Persons TOGETHER Launches Across the Nation 25536 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 1Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 3Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 25533 1Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 25533 2bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 1bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 2bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 3
...alix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) today ann...rials related to the Company,s products,will be pr...ill be,held May 19-24, 2007. Digestive Disease Wee...eeting in the world for the GI,professional. Every...earchers and academics from around the world who d...
... safety and,efficacy of first FDA-approved nebuliz...to severe COPD --, NAPA, Calif., May 16, 2007 /PRN...data presentations will be given at the,Internatio...TS) on,Sunday, May 20, at the Moscone Center in Sa...II clinical data demonstrating the,safety and effi...
Other Medicine Technology:Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4
(Date:12/2/2008)...swire/ -- TYRX, Inc., a leader in the development ...oducts, today announced the appointment of David E... for commercial operations. , , Mr. Elliot ...device industry. Mr. Elliot joins TYRX from Valam ...ng laser-based antimicrobial and vascular plaque d...
(Date:12/2/2008)...ire/ -- BioIQ , the leader in consumer-friendly h... , who provides services that include wellness, he... care management as well as case management of acu...ployers, and government agencies, will work togeth...orting tools as part of Alere,s Personal Health So...
(Date:12/2/2008)...s form an integral part of most of,original equip...fore become,essential for service providers in th...ain competitive and constantly improve their servi...o: http://www.newscom.com/cgi-bin/prnh/20081117/...llivan ( http://www.medicalimaging.frost.com ),Eu...
(Date:12/2/2008)...lect and disseminate pharmacy experience and knowl...(PRWEB) December 2, 2008 -- Pharmacy OneSource, I...e to focus public and industry attention on medic...SPEAK will occur during the American Society of He...al Meeting, to be held December 7-11 in Orlando, F...
Breaking Medicine News(10 mins):Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:BioIQ and Alere to Provide At-Home Biometric Screening Tests to Employees 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2
...ts in Britain have said that The World Bank did no...bly to keep up the promised sum of $500 million// ...o have manipulated data, with no adequate infrastr... of such a magnitude, reach completion. It is also...
...orities have declared that they will be launching ...curb infant and child deaths. This emergency vacci... and aims to protect nearly thousands of children ...s and five years. Nearly 1,600 cases of measles h...
...y done on 179 stroke patients, it was found that t... damage when they had stroke. The three drug// a c...tor for blood pressure control, and a cholesterol-...rk synergistically to reduce the amount of brain t...
... suggested that women who drink insufficient milk ...due to concerns about allergies may inhibit// thei...study were pubished in the Canadian Medical Associ...e study. All were non-smokers. However, on compari...
Other Medicine News:Health News:Limiting milk can hamper Babies’ Growt 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: